Skip to the page

Data / Form D filings / Santiste Medical Inc.

Santiste Medical Inc.: Form D filings

Santiste Medical Inc., a biotechnology company in Princeton, NJ, filed 2 Form D notices with the SEC between 2020 and 2023. The latest, on March 24, 2023, reports $89,000 sold of an offering with no set size to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
307 WENDOVER DRIVE, Princeton, NJ, 08549
Phone
(609) 921-1991
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1830849

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 24, 2023New noticeIndefinite$89,0008Nov 4, 2022sec.gov
Nov 4, 2020New noticeIndefinite$186,0007Jun 15, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Walter GreenblattExecutive Officer, Director
Mark EisenachExecutive Officer, Director

Other biotechnology companies in New Jersey that filed recently

Every Form D from the week of Mar 20, 2023 · All recent filings in New Jersey · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Santiste Medical Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.